In recent trading session, CVS Health Corp (NYSE:CVS) saw 1.6 million shares changing hands at last check today with its beta currently measuring 0.54. Company’s recent per share price level of $61.17 trading at $0.7 or 1.16% at last check today assigns it a market valuation of $77.38B. That most recent trading price of CVS’s stock is at a discount of -18.54% from its 52-week high price of $72.51 and is indicating a premium of 28.79% from its 52-week low price of $43.56.
For CVS Health Corp (CVS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.77. Splitting up the data highlights that, out of 20 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 6 suggested the stock as a Hold whereas 14 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
CVS Health Corp (NYSE:CVS) trade information
Upright in the green today for gaining 1.16%, in the last five days CVS remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $61.17 price level, adding 7.97% to its value on the day. CVS Health Corp’s shares saw a change of 36.27% in year-to-date performance and have moved -8.66% in past 5-day. CVS Health Corp (NYSE:CVS) showed a performance of -10.77% in past 30-days.
Wall Street analysts have assigned a consensus price target of 66 to the stock, which implies a rise of 7.32% to its recent value today. Analysts have been projecting 66 as a low price target for the stock while placing it at a high target of 77. It follows that stock’s current price would drop -7.9% in reaching the projected high whereas dropping to the targeted low would mean a loss of -7.9% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -6.37% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 12.55% while estimates for its earnings growth in next 5 years are of 14.16%.
CVS Health Corp (NYSE:CVS)’s Major holders
VANGUARD GROUP INC is the top institutional holder at CVS for having 116.35 million shares of worth $6.87 billion. And as of 2024-06-30, it was holding 9.2635 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 100.15 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.9738 of outstanding shares, having a total worth of $5.91 billion.
On the other hand, Dodge & Cox Funds-Dodge & Cox Stock Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 46.04 shares of worth $2.81 billion or 3.64% of the total outstanding shares. The later fund manager was in possession of 39.44 shares on Dec 31, 2024 , making its stake of worth around $2.41 billion in the company or a holder of 3.12% of company’s stock.
